Quality Assurance in Radiotherapy (RT)-Specific Trials: Indian Scenario
A. Mahata(Tata Medical Center), Sanjoy Chatterjee(Tata Medical Center), Tapesh Bhattacharyya(Tata Medical Center), Rimpa Basu Achari(Tata Medical Center), S. Mandal(Bose Institute), Santam Chakraborty(Tata Medical Center), Indranil Mallick(Tata Medical Center), Moses Arunsingh(Tata Medical Center)
Cited by 1
Related Papers
‘Plan of the day’ adaptive radiotherapy for bladder cancer using helical tomotherapy
|Radiotherapy and Oncology|2011|88
Human papillomavirus in head and neck cancer in India: Current status and consensus recommendations
|South Asian Journal of Cancer|2017|48
Prognostic factors in oropharyngeal cancer – analysis of 627 cases receiving definitive radiotherapy
|Acta Oncologica|2009|42
HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis
|Radiotherapy and Oncology|2022|42